Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NOS1 | P29475 | 1/20 | 0.33 |
| ▸ | PDPK1 | O15530 | 1/20 | 0.31 |
| ▸ | SCN9A | Q15858 | 1/20 | 0.31 |
| ▸ | CA1 | P00915 | 2/20 | 0.31 |
| ▸ | CA2 | P00918 | 2/20 | 0.31 |
| ▸ | CA9 | Q16790 | 2/20 | 0.31 |
| ▸ | CA12 | O43570 | 1/20 | 0.31 |
| ▸ | CA3 | P07451 | 1/20 | 0.31 |
| ▸ | CA4 | P22748 | 1/20 | 0.31 |
| ▸ | CA6 | P23280 | 1/20 | 0.31 |
| ▸ | CA5A | P35218 | 1/20 | 0.31 |
| ▸ | CA7 | P43166 | 1/20 | 0.31 |
| ▸ | CA13 | Q8N1Q1 | 1/20 | 0.31 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.31 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29972355 | 0.85 | PKM (0.37) | PDPK1CA1CA2CA9ADORA1 | |
| SCHEMBL29972906 | 0.81 | IDH1 (0.40) | — | |
| SCHEMBL29972979 | 0.80 | — | — | |
| SCHEMBL29972741 | 0.77 | GAA (0.35) | PDPK1 | |
| SCHEMBL23019360 | 0.66 | KDR (0.41) | ADORA1 | |
| SCHEMBL2745624 | 0.64 | TLR8 (0.33) | NOS1 | |
| SCHEMBL28875448 | 0.63 | TRPA1 (0.31) | — | |
| SCHEMBL20161346 | 0.62 | TGFBR1 (0.34) | — | |
| SCHEMBL20090330 | 0.60 | IDH1 (0.31) | — | |
| SCHEMBL30927740 | 0.60 | ULK1 (0.43) | ADORA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115381832-A | Treatment of cancer | 深圳明赛瑞霖药业有限公司 | 2022-11-25 | — | — | CN | disclosed |